COVID-19 increases risks of neurological problems
Persons infected with the COVID-19 virus are at an increased risk of developing neurological conditions in the first year after infection, researchers reported on Sept. 22 in Nature… read more.
Persons infected with the COVID-19 virus are at an increased risk of developing neurological conditions in the first year after infection, researchers reported on Sept. 22 in Nature… read more.
Tenecteplase, a clot buster used off-label for treating ischemic stroke, outperforms alteplase, the standard treatment, in health outcomes and cost, researchers reported on September 23, 2022 in Stroke…. read more.
Treatment with the biologic drug dupilumab brings relief to children younger than 6 years-old who are suffering with moderate-to-severe atopic dermatitis (eczema) The findings were published on Sept…. read more.
Results from a small study suggest that the antiviral drug tecovirimat is safe and effective for the treatment of monkeypox. The findings were published on August 26, 2022… read more.
In over 90% of cases, statin therapy is not related to muscle pain, researchers from a large new study reported on August 29, 2022 in The Lancet. “The… read more.
A research team from the lab of Quing Zhu, the Edwin H. Murty Professor of Engineering in the Department of Biomedical Engineering at the McKelvey School of Engineering… read more.
Researchers report that vaccination against Covid-19 during pregnancy is not related to an increase in risk of preterm birth, small size for gestational age at birth or stillbirth…. read more.
Treatment with dupilumab appears to improve survival rates for patients with moderate to severe COVID-19. Researchers reported these findings on August 16, 2022 in Open Forum of Infectious… read more.
Multiple does of the Bacillus Calmette-Guerin (BCG) vaccine appears to offer patients with type 1 diabetes strong protection against COVID-19, researchers reported on August 15, 2022 in Cell… read more.
In a Phase I/II trial, cancer treatment with pralsetinib has produced high response rates in patients with RET gene fusions, regardless of tumor type, researchers reported on Aug.12,… read more.
Dietary supplementation with vitamin D does not appear to lower the risk of fractures in healthy adults, researchers reported on July 27, 2022 in the New England Journal… read more.
People who are smokers or vapers at the time of hospitalization for COVID-19 are more likely than non-smokers/non-vapers to suffer severe complications from their SARS-CoV-2 infection. The findings… read more.